TRAW icon

Traws Pharma
TRAW

Overview Fund Activity

28 hedge funds and large institutions have $1.27M invested in Traws Pharma in 2023 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 5 increasing their positions, 5 reducing their positions, and 2 closing their positions.

Holders
28
Holders Change
+4
Holders Change %
+16.67%
% of All Funds
0.45%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
5
Reduced
5
Closed
2
Calls
$5K
Puts
–
Net Calls
+$5K
Net Calls Change
-$17K

Top Buyers

1
Susquehanna International Group
1
Susquehanna International Group
Pennsylvania
$22.2K
2
Geode Capital Management
2
Geode Capital Management
Massachusetts
$139K
3
TSS
3
Two Sigma Securities
New York
$7.78K
4
TRCT
4
Tower Research Capital (TRC)
New York
$2.69K
5
TWC
5
TD Waterhouse Canada
Ontario, Canada
$87

Top Sellers

1
Renaissance Technologies
1
Renaissance Technologies
New York
$131K
2
Two Sigma Advisers
2
Two Sigma Advisers
New York
$67.5K
3
Two Sigma Investments
3
Two Sigma Investments
New York
$88.7K
4
UBS Group
4
UBS Group
Switzerland
$45
5
Millennium Management
5
Millennium Management
New York
$8.41K
Name Market Value Shares Shares
Change 		Shares
Change %
Qube Research & Technologies (QRT)
26
Qube Research & Technologies (QRT)
United Kingdom
$2 3 +3 New
S
27
SignatureFD
Georgia
– – -400 Closed
Fidelity Investments
28
Fidelity Investments
Massachusetts
– – -3 Closed
CFGS
29
Concourse Financial Group Securities
Alabama
– – – –
Simplex Trading
30
Simplex Trading
Illinois
$0 107 +107 New
Royal Bank of Canada
31
Royal Bank of Canada
Ontario, Canada
$0 207 +161 +350%
1
2